Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Ambrisentan

Menu
$ API Ref.Price (USD/KG) : 41,719Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6GILEAD

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 9474752

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1754

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2027-12-11

blank

02

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 9474752

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1754

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2027-12-11

blank

03

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 9549926

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1965

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-14

blank

04

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 8377933

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1754

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2027-12-11

blank

05

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 8377933

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1754

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF P...

Patent Expiration Date : 2027-12-11

blank

06

arrow
AAPS 2024
Not Confirmed
arrow
AAPS 2024
Not Confirmed

AMBRISENTAN

US Patent Number : 9549926

Drug Substance Claim :

Drug Product Claim :

Application Number : 22081

Patent Use Code : U-1965

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-14

blank